Food and Drug Administration (FDA)
Guidance for Industry: Establishing pregnancy exposure registries.
Rockville, MD: US Department of Health and Human Services, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research; 2002.
::: Available Here :::
Scheuerle A, Tilson H.
Birth defect classification by organ system: A novel approach to heighten teratogenic signaling in a pregnancy registry.
Pharmacoepidemiology and Drug Safety 2002;11:465-475
Copyright © 2005
All rights reserved